With a Bacherlor of Science in Biopharmaceutical Science and Masters of Science in Chemistry from the University of Ottawa, Trevor started with Avivagen in 2006 to carry out fundamental R&D related to OxC-betaTM technology. He is currently directing the Chemistry Group, with a lead role in Product Research and Development, Quality Control, and Regulatory Affairs.